A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Clinical trial NCT07309445 · RECRUITING
Trial details
- NCT number
- NCT07309445
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-12
- Primary completion
- 2029-03-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.